• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Protalix BioTherapeutics Inc - Articles and news items

Pfizer logo

Pfizer and Protalix BioTherapeutics announce FDA approval of pediatric Indication for ELELYSO™ (taliglucerase alfa) for injection

Industry news / 29 August 2014 / Pfizer

…for intravenous use for the treatment of type 1 Gaucher disease.

Pfizer logo


Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +